Retour
Fourchette du Jour
17,25 €
18,10 €
Fourchette 52 Semaines
12,88 €
19,63 €
Volume
316 761
Moyenne 50J / 200J
14,26 €
/
14,26 €
Clôture Précédente
18,10 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,7 | 0,3 |
| P/B | 5,3 | 2,9 |
| ROE % | -64,1 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
31,20 €
+75.4%
Low: 25,00 €
High: 37,00 €
BPA Prévisionnel
-1,94 €
CA Est.
0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,93 €
2,93 € – 2,93 €
|
820 M | 4 |
| FY2029 |
0,99 €
0,99 € – 0,99 €
|
490 M | 4 |
| FY2028 |
-0,54 €
-1,89 € – 2,95 €
|
220 M | 10 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -131,56M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-64,06%
ROIC-37,53%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio6,29
Interest Coverage-30,34
Valorisation
P/E Ratio
-9,65
P/B Ratio5,34
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -183,79M |
| ROE | -64,06% | ROA | -41,76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -131,56M |
| ROIC | -37,53% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 6,29 |
| Interest Coverage | -30,34 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,65 | P/B Ratio | 5,34 |
| P/S Ratio | N/A | PEG Ratio | -0,19 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,77B | Enterprise Value | 1,52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -183,79M | -108,68M | -95,73M | -56,80M | -93,04M |
| EPS (Diluted) | -2,06 | -0,15 | -2,44 | -1,53 | -3,40 |
| Gross Profit | 0,0 | -527 000,0 | -3,16M | 0,0 | 0,0 |
| Operating Income | -166,31M | -103,92M | -93,87M | -66,33M | -93,85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 440,10M | 302,15M | 124,54M | 169,99M | 164,00M |
| Total Liabilities | 107,77M | 60,70M | 46,41M | 19,08M | 12,34M |
| Shareholders' Equity | 332,33M | 241,45M | 78,13M | 150,92M | 151,66M |
| Total Debt | 0,0 | 21,85M | 14,13M | 72 000,0 | 0,0 |
| Cash & Equivalents | 257,84M | 273,74M | 99,70M | 142,14M | 133,54M |
| Current Assets | 419,32M | 281,62M | 103,87M | 146,06M | 137,22M |
| Current Liabilities | 66,70M | 38,85M | 32,25M | 17,89M | 10,41M |